从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均51.42倍，行业中值37.44倍，超研股份排 名第96位。 股东方面，截至2025年3月31日，超研股份股东户数26755户，较上次减少23411户，户均持股市值35.28 万元，户均持股数量2.76万股。 7月7日，超研股份今日收盘26.63元，上涨2.86%，滚动市盈率PE（当前股价与前四季度每股收益总和的 比值）达到72.07倍，创63天以来新低，总市值114.06亿元。 最新一期业绩显示，2025年一季报，公司实现营业收入9843.24万元，同比28.69%；净利润3932.20万 元，同比47.70%，销售毛利率73.83%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13超研股份72.0778.358.82114.06亿行业平均 51.4249.164.50106.60亿行业中值37.4437.842.5151.15亿1九安医疗10.2110.330.80172.35亿2英科医疗 10.4111.230.93164.55亿3新华医疗14.3013.251.1791.67亿4奥美医疗15.3415.031.5855.41亿5振德医疗 ...

Core Viewpoint - Chao Yan Co., Ltd. has a closing price of 24.78 yuan, down 1.82%, with a rolling PE ratio of 67.06 times and a total market value of 10.614 billion yuan, indicating a higher valuation compared to the industry average [1] Company Summary - Chao Yan Co., Ltd. specializes in the research, production, and sales of medical imaging equipment and industrial non-destructive testing equipment, with key products including industrial ultrasound, medical ultrasound, X-ray, and accessories [1] - The company has established a strong market presence and customer base, with its industrial ultrasound non-destructive testing products recognized as a Guangdong Province brand product [1] - In 2022, the company received the second prize of the National Defense Technology Invention Award from the Ministry of Industry and Information Technology for its project on "New Technology for High-Precision Non-Destructive Testing of Complex Large Components and Its Major Applications" [1] Financial Performance - For the first quarter of 2025, the company reported operating revenue of 98.4324 million yuan, a year-on-year increase of 28.69%, and a net profit of 39.322 million yuan, a year-on-year increase of 47.70%, with a gross profit margin of 73.83% [1] Industry Summary - The average PE ratio for the medical device industry is 51.29 times, with a median of 37.02 times, positioning Chao Yan Co., Ltd. at the 96th rank within the industry [1][2] - The industry average market value is 10.675 billion yuan, while the median market value is 5.063 billion yuan [2]

Group 1 - The core viewpoint of the news is that Chao Yan Co., Ltd. has a high rolling price-to-earnings (PE) ratio of 70.66, significantly above the industry average of 50.64, indicating a premium valuation in the medical device sector [1][2] - As of June 9, the company's stock closed at 26.11 yuan, with a market capitalization of 11.184 billion yuan, reflecting a 1.28% increase [1] - The company has experienced a net outflow of main funds amounting to 245.27 million yuan on June 9, with a total outflow of 2,328.49 million yuan over the past five days [1] Group 2 - Chao Yan Co., Ltd. specializes in the research, production, and sales of medical imaging equipment and industrial non-destructive testing equipment, with key products including industrial ultrasound, medical ultrasound, and X-ray equipment [1] - The company has established a strong market presence and customer base, with its industrial ultrasound non-destructive testing products recognized as a Guangdong Province brand product [1] - In 2022, the company received a second-class award for national defense technology invention from the Ministry of Industry and Information Technology for its project on "New Technology for High-Precision Non-Destructive Testing of Complex Large Components and Its Major Applications" [1] Group 3 - The latest financial results for the first quarter of 2025 show that the company achieved an operating income of 98.4324 million yuan, representing a year-on-year increase of 28.69%, and a net profit of 39.3220 million yuan, up 47.70% year-on-year, with a gross profit margin of 73.83% [1]